Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

More Filters

We narrowed to 17,703 results for: puromycin

Clear keywords
Showing: 2981 - 3000 of 17703 results

  8. pCRISPaint-mScarlet-PuroR [M1G]

    Plasmid
    #171809
    Purpose
    Universal donor plasmid for CRISPitope method encoding mScarlet fluorescent protein and puromycin resistance cassette [p.M1G]
    Depositor
    Michael Hoelzel
    Publication
    Effern et al Immunity. 2020 Sep 15;53(3):564-580.e9.
    Has service
    50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNA
    Insert
    mScarlet-T2A-PuroR
    Use
    Gene tagging
    Mutation
    PuroR: Changed Methionin 1 to Glycine.
    Available since
    July 20, 2021
    Availability
    Academic Institutions and Nonprofits only
    Cited by
    171809-plasmid-map-sequence-id-337981

    Enlarge

  9. pGAPTrap-eGFP-IRESMuro

    Plasmid
    #82504
    Purpose
    Vector targeting the eGFP gene to the GAPDH locus of human cells. eGFP is expressed from a 2A sequence at the C terminus of GAPDH. Puromycin resistance is encoded by the Muro gene.
    Depositor
    Ed Stanley
    Publication
    Kao et al Stem Cell Reports. 2016 Sep 1. pii: S221
    Insert
    eGFP-IRESMuro
    Use
    Synthetic Biology
    Expression
    Mammalian
    Available since
    Sept. 30, 2016
    Availability
    Academic Institutions and Nonprofits only
    82504-plasmid-map-sequence-id-156573

    Enlarge

  11. P3-dCas9-Tet1-GFP-Puro

    Plasmid
    #190728
    Purpose
    Expression of human spdCas9-Tet1 fusion for targeted DNA methylation in mammalian cell. EGFP-puromycin double marker under an independent CMV promoter. Cloning backbone for spgRNA (BbsI)
    Depositor
    Maja Jagodic
    Publication
    Pahlevan Kakhki et al Nat Commun. 2024 Jul 30;15(1):6419. doi:
    Has service
    50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNA
    Insert
    dCas9-tet1
    Use
    CRISPR
    Tags
    3XFLAG and SV40 NLS
    Expression
    Mammalian
    Mutation
    Changed Pro434 codon from CCG to CCC and Gly468 f…
    Promoter
    pCAG
    Available since
    July 23, 2024
    Availability
    Academic Institutions and Nonprofits only
    190728-plasmid-map-sequence-id-381333

    Enlarge

  13. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-C145A-nsp6

    Plasmid
    #247702
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with C145A mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with C145A fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    C145A
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247702-plasmid-map-sequence-id-495600

    Enlarge

  14. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-T21I-nsp6

    Plasmid
    #247703
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with T21I mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with T21I fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    T21I
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247703-plasmid-map-sequence-id-491576

    Enlarge

  15. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-L50F-nsp6

    Plasmid
    #247704
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with L50F mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with L50F fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    L50F
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247704-plasmid-map-sequence-id-503235

    Enlarge

  16. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-E166V-nsp6

    Plasmid
    #247705
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with E166V mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with E166V fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    E166V
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247705-plasmid-map-sequence-id-491573

    Enlarge

  17. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-E166A-nsp6

    Plasmid
    #247706
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with E166A mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with E166A fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    E166A
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247706-plasmid-map-sequence-id-491574

    Enlarge

  18. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-S144A-nsp6

    Plasmid
    #247707
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with S144A mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with S144A fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    S144A
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247707-plasmid-map-sequence-id-503505

    Enlarge

  19. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-T304I-nsp6

    Plasmid
    #247708
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with T304I mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with T304I fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    T304I
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247708-plasmid-map-sequence-id-501776

    Enlarge

Showing: 2981 - 3000 of 17703 results